Dupilumab reduces inflammation and restores the skin barrier in patients with atopic dermatitis.

Rohner, Maria Helena; Thormann, Kathrin; Cazzaniga, Simone; Yousefi, Shida; Simon, Hans-Uwe; Schlapbach, Christoph; Simon, Dagmar (2021). Dupilumab reduces inflammation and restores the skin barrier in patients with atopic dermatitis. Allergy, 76(4), pp. 1268-1270. Wiley-Blackwell 10.1111/all.14664

[img] Text
all.14664.pdf - Accepted Version
Restricted to registered users only until 19 November 2021.
Available under License Publisher holds Copyright.

Download (4MB) | Request a copy
[img] Text
all.14664.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (990kB) | Request a copy

Item Type:

Journal Article (Further Contribution)

Division/Institute:

04 Faculty of Medicine > Department of Dermatology, Urology, Rheumatology, Nephrology, Osteoporosis (DURN) > Clinic of Dermatology
04 Faculty of Medicine > Pre-clinic Human Medicine > Institute of Pharmacology

UniBE Contributor:

Cazzaniga, Simone; Yousefi, Shida; Simon, Hans-Uwe; Schlapbach, Christoph and Simon, Dagmar

Subjects:

600 Technology > 610 Medicine & health

ISSN:

0105-4538

Publisher:

Wiley-Blackwell

Language:

English

Submitter:

Sandra Nyffenegger

Date Deposited:

05 Jan 2021 14:59

Last Modified:

13 Apr 2021 01:32

Publisher DOI:

10.1111/all.14664

PubMed ID:

33210741

Uncontrolled Keywords:

atopic dermatitis dupilumab epidermal barrier interleukin-13 type 2 inflammation

BORIS DOI:

10.48350/149510

URI:

https://boris.unibe.ch/id/eprint/149510

Actions (login required)

Edit item Edit item
Provide Feedback